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The nitric oxide synthase-like protein from Bacillus cereus (bcNOS) has been cloned, expressed, and characterized. This small
hemeprotein (356 amino acids in length) has a mass of 43 kDa and forms a dimer. The recombinant protein showed similar
spectral shifts to the mammalian NOS proteins and could bind the substrates L-arginine and N
G-hydroxy-L-arginine as well as the
ligand imidazole. Low levels of activity were recorded for the hydrogen peroxide-dependent oxidation of N
G-hydroxy-L-arginine
and L-arginine by bcNOS, while a reconstituted system with the rat neuronal NOS reductase domain showed no activity. The
recombinant bcNOS protein adds to the complement of bacterial NOS-like proteins that are used for the investigation of the
mechanism and function of NO in microorganisms.
1.Introduction
Nitric oxide has many diverse functions in the mammalian
body and is produced in mammals by a family of nitric oxide
synthase enzymes (NOS: EC 1.14.13.39) [1]. These enzymes
are composed of an N-terminus oxygenase domain contain-
ing a heme, tetrahydrobiopterin (H4B), and the substrate L-
arginine as well as a C-terminus reductase domain. There
are over thirty NOS-like proteins in prokaryotes including
eight diﬀerent types reported in bacilli [2]. Bacterial NOS-
like enzymes lack the associated NOS reductase domain
found in mammalian enzymes [3]. The bacterial NOSs have
many properties in common with the mammalian oxygenase
domain including dimer structure, L-Arginine as a substrate,
andtypicalhemespectroscopy[2].Verylittleisknownabout
the function of these proteins in prokaryotes, and they are
not required for nitriﬁcation and denitriﬁcation pathways
[4].
The opportunistic pathogen B. cereus causes food poi-
soning and is closely related to the animal and human
pathogen B. anthracis used as a biological weapon as well
as the insect pathogen B. thuringiensis that is used as a
pesticide. We report the cloning, expression, puriﬁcation,
and characterization of a NOS-like protein from Bacillus
cereus (bcNOS).
2.MaterialsandMethods
2.1. Materials. A l lr e a g e n t sw e r ep u r c h a s e df r o mS i g m a -
Adrich Canada Ltd. (Oakville, ON, Canada) and Fisher-
Scientiﬁc Ltd. (Ottawa, ON, Canada) and were of high
quality chemical grade.
2.2. Molecular Biology. The bcNOS gene from B. cereus
(ATCC strain number 10987) was ampliﬁed by PCR from
genomicDNA.ThefollowingPCRprimersgeneratedanNde
I site (bold) before the 5  start codon in BCNOSF1 and an
EcoRIsite(underlined)afterthe3  stopcodoninBCNOSR1:
BCNOSF1, 5 -GAA GAT CTCA T AT G A GTA AAA CGA
AGC AAT TAA TAG AGG AAG CG-3 ;B C N O S R E V ,5  -
GGG AAT TCC TAT TTA TGA AAA AAA TTC GGC TTC
AAAATTTC-3 .Theampliﬁedfragmentwasclonedintothe
pET28a expression vector (Novagen, Madison, WI), which
contains a His6coding region upstream from the Nde I site.
2.3. Expression and Puriﬁcation of Proteins. E. coli strain
BL21(DE3) pLysS transfected with the bcNOS plasmid and
grown in Luria-Bertani broth containing 100μg/mL ampi-
cillin, induced at an OD (600nm) of 0.6 with 1mM IPTG
and grown for 4 hours and then harvested. The recombinant2 Biochemistry Research International
bcNOS was puriﬁed from the bacterial cells using metal
chelating chromatography [5] (see Supplementary Material
available online at doi: 10.1155/2010/489892). Recombinant
rat nNOS reductase protein was overexpressed in Escherichia
coli strain BL21(DE3) and puriﬁed as previously described
[6].
2.4. Mass Spectrometry and Chromatography. Mass spec-
trometry of the puriﬁed bcNOS was performed at the
WATSPEC Mass Spectroscopy Facility at the University of
Waterloo [5]. Gel exclusion chromatography was used to
estimate the molecular weight of bcNOS dimer [5].
2.5. Spectroscopy. Spectroscopy performed on a Varian-
Cary 1. The bcNOS exhibited a typical heme peak around
400nm. Enzyme (10μM) was incubated in the presence of
1mM imidazole, 1mM L-arginine, 100μMH 4B, or CO gas.
Diﬀerence spectroscopy was used to measure the binding
aﬃnities of imidazole, NOHA, and L-arginine as previously
described [7].
2.6. Catalytic Activity Assays. The H2O2-dependent bcNOS
oxidation of NOHA and L-arginine to nitrite was monitored
at 25
◦C on a 96-well plate reader as presiously reported [8,
9]. The hemoglobin capture assay [10] was used to monitor
nitric oxide production from bcNOS in the presence of L-
arginine and the rat neuronal NOS reductase domain.
3. Results andDiscussion
The sequence alignment of the bcNOS protein with the
NOS-like proteins from B. subtilis (bsNOS), Staphylococcus
aureus (saNOS), and D. radiodurans (deiNOS) revealed a
42 to 52% identity and 61 to 68% conservation of the
sequence and full conservation of the residues involved
in binding to the heme (see Figure 1 in supplementary
materials). A comparison of the bcNOS protein with the
human inducible NOS (iNOS) revealed a 40% identity and
57% conservation of the sequence. Recombinant bcNOS
was puriﬁed to greater than 90% homogeneity based upon
SDS-PAGE and mass spectrometry analysis (see Figure 2 in
supplementary materials). A yield of 8mg of pure bcNOS
was obtained per liter of culture. Nondenaturing native-
PAGE and gel exclusion chromatography both showed that
bcNOS forms a dimer.
The bcNOS UV-visible spectrum showed the presence of
a heme chromophore in a high spin state (Figure 1). The
observed spectral changes of bcNOS due to the binding of
diﬀerent heme ligands are summarized in Table 1. The char-
acteristic Soret absorbance peak of 399nm was observed for
ferric bcNOS (Figure 1), likely corresponding to a mixture
of 5-coordinated high-spin species and a water-bound 6-
coordinated low-spin species. The binding of DDT shifts the
equilibrium towards a fully 5-coordinated high-spin species.
When H4B was added the Soret peak shifted to 397nm.
The slight blue shift in the spectrum indicates that the H4B
displaced the DTT ligand. Adding L-arginine produced the
same result as H4B, resulting in a Soret absorbance peak



























Figure 1: Spectral graphs of bcNOS with heme bind ligands. The
UV-visible spectrum of bcNOS (—) protein was performed as
stated in the Materials and Methods. Protein was incubated in the
presence of H4B( -.. -), L-arginine (- - -), imidazole (- . -), and CO
(....).
shift to 397nm. The addition of imidazole resulted in a
low-spin heme state with a peak absorbance of 426nm that
is typical of imidazole serving as a distal sixth ligand in
the active site of NOS enzymes. Dithionite-reduced, carbon
monoxide (CO) bound bcNOS gave absorbance peaks at
443nm and 545nm, comparable to the mammalian iNOS
and neuronal NOS (nNOS) oxygenase domains and other
bacterial NOS-like proteins (Table 1) indicating a similar
heme iron coordination structure.
Diﬀerence spectrometry, used to study heme-substrate
interactions, revealed that a substrate-binding site exists in
bcNOSclosetothehemegroupandthatthissiteiscapableof
binding imidazole, NOHA, or L-arginine. The displacement
of heme-bound imidazole due to the binding of NOHA or L-
arginine was monitored to determine the binding aﬃnity of
NOHAandL-argininetobcNOS.Double-reciprocalanalysis
of the binding of imidazole to bcNOS gave a Kd value of 181
± 13μM. The binding aﬃnities of NOHA and L-arginine
were much greater with Ks values of 1.12 ± 0.01 and 11 ±
3, respectively. The apparent binding aﬃnity of L-arginine
to bcNOS was found to be similar to those determined for
other bacterial NOS proteins and the mammalian iNOSoxy
protein (Table 2). This is consistent with bcNOS containing
a conserved glutamate residue found to be essential for high
aﬃnity L-arginine binding in mammalian NOS enzymes
[13].
Tetrahydrobiopterin-free nNOS can oxidize NOHA or
L-arginine to nitrite in the presence of H2O2 [14]. Despite
low binding constants for both NOHA and L-arginine, low
levels of activity were found for the bcNOS protein in theBiochemistry Research International 3
Table 1: Soret and visible spectral properties (wavelength (nm) at peak absorbance) of bcNOS, deiNOS, bsNOS, nNOSoxy, and iNOSoxy
with L-arginine and other various heme ligands.
Enzyme-ligand complex bcNOS deiNOS a bsNOS b nNOSoxy a iNOSoxy b
Soret Visible Soret Visible Soret Soret Visible Soret
Ferric enzyme 399 650 N.D. N.D. 402 N.D. N.D. 418
+H 4B 397 650 N.D. N.D. 399 N.D. N.D. 400
+ L-Arg 397 645 393 650 398 393 650 401
+ L-Arg + H4B 395 643 N.D. N.D. 395 N.D. N.D. 396
+ Imidazole 426 547 427 550 426 427 550 427
+ Dithiothreitol 399 650 380, 460 650 400 380, 460 650 375, 459
Ferrous-CO 443 545 444 540 445 444 540 444
ataken from [11]. btaken from [12]. N.D.: not determined. nNOSoxy: neuronal NOS oxygenase domain. iNOSoxy: inducible NOS oxygenase domain.
Table 2: Comparison of the binding properties of bcNOS to other bacterial NOS-like and mammalian NOS oxygenase domain proteins.
Binding constants (μM) bcNOS bsNOS a deiNOS b iNOSoxy a nNOSoxy b
Kd imidazole 181 ± 13 384 ± 10 — 158 ± 6—
Kobs L-Arg 596 ± 161 129 ± 29 7 ± 10 175 ± 45 5 ± 4
Ks L-Arg 11 ± 34 . 8 ± 0.1 — 16.1 ± 0.7 —
Ks NOHA 1.12 ± 0.01 — — — —
ataken from [8]. btaken from [11]. iNOSoxy: inducible NOS oxygenase domain. nNOSoxy: neuronal NOS oxygenase domain.
presence of H2O2 and either NOHA (0.100 ± 0.014min
−1)
or L-arginine (0.048 ± 0.001minute). When compared
to mammalian NOS enzymes, slow turnover numbers for
H2O2-supported NOHA oxidation have also been reported
for other bacterial NOS-like proteins [11, 15, 16]. The
addition of H4B did not signiﬁcantly increase the activity of
bcNOS, but in the presence of NOHA and THF the activity
doubled (0.231 ± 0.023). This suggests that a biological
ligand, such as THF or a related pterin, may be required
by bcNOS for catalytic activity. A similar catalytic rate was
determined for saNOS in the absence of a cofactor (0.15 ±
0.01nmol nitrite min
−1nmol saNOS) with no increase in
activity observed in the presence of THF [17]a n dar e c e n t
report indicates that THF may replace H4Ba sar e d o x - a c t i v e
cofactor in deiNOS [15].
The bcNOS protein was not catalytically active when
coupled with the rat nNOS reductase domain protein in
the presence of L-arginine and NADPH despite the fact
that the nNOS reductase domain protein readily transfers
electrons to reduce cytochrome c [6]. The relevance of such
a reconstituted system comes into question, as a reductase
protein similar to the mammalian NOS reductase domain
could not be found in the B. cereus genome. Bacterial
ﬂavodoxins have been reported to support nitric oxide
production by B. subtilis nitric oxide synthase [16]. We were
unable to identify the electron donor(s) of bcNOS which
is consistent with a recent report showing that bacterial
NOS proteins do not appear to accept electrons from a
speciﬁc reductase but more likely accept electrons from
several diﬀerent sources [18].
T h eN Op r o d u c e db yb a c t e r i a lN O Se n z y m e sh a sb e e n
associated with a number of novel functions. In Streptomyces
NOS mediates the nitration of the tryptophan moiety
of the phytotoxin dipeptide L-tryptophan-L-phenylalanine
[19]. Disruption of the NOS gene in B. subtilis renders
the strain more susceptible to oxidative damage [20]. Our
B. cereus nos gene knock out strain was also found to be
more vulnerable to hydrogen peroxide exposure (results
not shown). Notably, B. anthracis derived-NO is correlated
with pathogen virulence and survival in macrophages [21].
Clearly, there are several unanswered questions regarding
bacterial NOS enzymes including cofactor requirements,
evolutionary traits, catalytic mechanism, their biological
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